Biontech Se
Clinical trials sponsored by Biontech Se, explained in plain language.
-
BioNTech tests new cancer drug in First-Ever human trial
Disease control Not yet recruitingThis is the first time the experimental drug BNT3214 will be given to people. The study aims to find a safe dose and see if it can help adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will test different dose levels and schedules…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial aims to outperform chemo for tough prostate cancer
Disease control Not yet recruitingThis study is testing if an experimental drug called BNT324 helps men with advanced prostate cancer live longer or live longer without their cancer getting worse, compared to the current standard chemotherapy. It will involve about 736 men whose cancer has spread and stopped resp…
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC